ABMD Stock Recent News

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "IoMT Wearable Devices Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The IoMT wearable devices market was valued at USD 34.93 billion in 2023. It is expected to grow at a CAGR of 23.0% during the forecast period of 2024-2032 and attain a market value of USD 225.1 billion in 2032. The patent landscape is driven by advancements in sensor technology, AI integration, and connectivity solutions, enhancing diagnostic accuracy and personalised treatment. The global IoMT wearable devices patent landscape report offers an in-depth analysis of the dynamic patent environment. It explores innovations in sensor technologies, AI integration, and advanced connectivity solutions that are shaping the future of IoMT wearables. The report provides detailed segmentation by product type, modality, and application, highlighting key patents and emerging trends.

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

There's a lot more ahead for these market giants.

Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.

The company is planting seeds for future growth.

The $16.6 billion acquisition shakes up MedTech.

Johnson & Johnson has outperformed the Dow so far this year.

A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.

Marking its biggest deal in nearly six years, Johnson & Johnson ( JNJ , Financial) announced on Tuesday it is buying Abiomed Inc. ( ABMD , Financial) for $16.6 billion in a bid to boost its cardiovascular business even as its spins off its consumer health division.

Abiomed, Inc. (NASDAQ:ABMD ) Q2 2023 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Jessica Moore - Vice President of Investor Relations, Johnson & Johnson. Joaquin Duato - Chief Executive Officer, Johnson & Johnson Michael Joaquin - Chairman, President and Chief Executive Officer Ashley McEvoy - Executive Vice President and Worldwide Chairman, Medtech Johnson & Johnson Joe Wolk - Chief Financial Officer, Johnson & Johnson Conference Call Participants Joanne Wuensch - Citibank Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Jayson Bedford - Raymond James Terence Flynn - Morgan Stanley Operator Its now pleasure to turn the conference over Vice President of Investor Relations, Jessica Moore.